2023 Q3 Form 10-Q Financial Statement

#000007633423000064 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $4.847B
YoY Change 14.52%
Cost Of Revenue $3.097B
YoY Change 10.8%
Gross Profit $1.750B
YoY Change 21.76%
Gross Profit Margin 36.1%
Selling, General & Admin $873.7M
YoY Change 4.53%
% of Gross Profit 49.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $84.87M
YoY Change 26.73%
% of Gross Profit 4.85%
Operating Expenses $873.7M
YoY Change 4.53%
Operating Profit $977.4M
YoY Change 24.12%
Interest Expense $134.5M
YoY Change 14.16%
% of Operating Profit 13.76%
Other Income/Expense, Net -$22.46M
YoY Change -86.5%
Pretax Income $820.4M
YoY Change 63.0%
Income Tax $169.4M
% Of Pretax Income 20.64%
Net Earnings $651.1M
YoY Change 67.79%
Net Earnings / Revenue 13.43%
Basic Earnings Per Share $5.07
Diluted Earnings Per Share $4.99
COMMON SHARES
Basic Shares Outstanding 128.4M shares
Diluted Shares Outstanding 130.4M shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $456.9M
YoY Change -12.45%
Cash & Equivalents $448.9M
Short-Term Investments $7.930M
Other Short-Term Assets $197.4M
YoY Change -50.32%
Inventory $3.029B
Prepaid Expenses
Receivables $2.850B
Other Receivables $296.1M
Total Short-Term Assets $6.830B
YoY Change -4.72%
LONG-TERM ASSETS
Property, Plant & Equipment $2.841B
YoY Change 3.16%
Goodwill $10.52B
YoY Change 1.34%
Intangibles $8.192B
YoY Change -2.34%
Long-Term Investments
YoY Change
Other Assets $1.183B
YoY Change -4.14%
Total Long-Term Assets $22.76B
YoY Change -0.11%
TOTAL ASSETS
Total Short-Term Assets $6.830B
Total Long-Term Assets $22.76B
Total Assets $29.59B
YoY Change -1.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.037B
YoY Change 0.92%
Accrued Expenses $1.308B
YoY Change -6.2%
Deferred Revenue $222.8M
YoY Change 71.45%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $3.594B
YoY Change 108.36%
Total Short-Term Liabilities $7.667B
YoY Change 39.43%
LONG-TERM LIABILITIES
Long-Term Debt $8.596B
YoY Change -29.76%
Other Long-Term Liabilities $671.5M
YoY Change -25.03%
Total Long-Term Liabilities $671.5M
YoY Change -25.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.667B
Total Long-Term Liabilities $671.5M
Total Liabilities $19.02B
YoY Change -10.22%
SHAREHOLDERS EQUITY
Retained Earnings $17.50B
YoY Change 10.22%
Common Stock $427.7M
YoY Change -5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.57B
YoY Change
Total Liabilities & Shareholders Equity $29.59B
YoY Change -1.21%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income $651.1M
YoY Change 67.79%
Depreciation, Depletion And Amortization $84.87M
YoY Change 26.73%
Cash From Operating Activities $650.0M
YoY Change 42.11%
INVESTING ACTIVITIES
Capital Expenditures $97.75M
YoY Change 16.98%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$4.801M
YoY Change -98.05%
Cash From Investing Activities -$55.99M
YoY Change -99.29%
FINANCING ACTIVITIES
Cash Dividend Paid $190.4M
YoY Change 11.24%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $176.6M
YoY Change -41.4%
Cash From Financing Activities -$617.9M
YoY Change -146.12%
NET CHANGE
Cash From Operating Activities $650.0M
Cash From Investing Activities -$55.99M
Cash From Financing Activities -$617.9M
Net Change In Cash -$26.26M
YoY Change -99.57%
FREE CASH FLOW
Cash From Operating Activities $650.0M
Capital Expenditures $97.75M
Free Cash Flow $552.2M
YoY Change 47.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Interest Expense
InterestExpense
134468000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
117794000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
7930000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
8390000 usd
CY2023Q3 ph Tradeaccountsreceivablenet
Tradeaccountsreceivablenet
2740420000 usd
CY2023Q2 ph Tradeaccountsreceivablenet
Tradeaccountsreceivablenet
2827297000 usd
CY2023Q3 ph Nontradeandnotesreceivable
Nontradeandnotesreceivable
296097000 usd
CY2023Q2 ph Nontradeandnotesreceivable
Nontradeandnotesreceivable
309167000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3028748000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2907879000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
307474000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
306314000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3594425000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3763175000 usd
CY2023Q3 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
18000 usd
CY2022Q3 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
1361000 usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
1384000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
1957000 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6944000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7437000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-63947000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1228000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
137995000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
137143000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16915000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
186579000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
38589000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
95135000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4768000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
107579000 usd
CY2023Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-220336000 usd
CY2022Q3 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-89455000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
136916000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8047000 usd
CY2023Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
51443000 usd
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
336444000 usd
CY2023Q3 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-53086000 usd
CY2022Q3 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
49378000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-78954000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1671000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
649959000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
457358000 usd
CY2022Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
89704000 usd
CY2023Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7146110000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
97746000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83555000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
710000 usd
CY2022Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11107000 usd
CY2023Q3 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
36691000 usd
CY2022Q3 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
441340000 usd
CY2023Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4477000 usd
CY2022Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7687000 usd
CY2023Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4027000 usd
CY2022Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
16467000 usd
CY2023Q3 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 usd
CY2022Q3 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
1405418000 usd
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4801000 usd
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-246438000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55994000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7927418000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1182000 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
559000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
79330000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
67241000 usd
CY2023Q3 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2883000 usd
CY2022Q3 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
CY2023Q3 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
169785000 usd
CY2022Q3 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
112430000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2000000000 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
176626000 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
301389000 usd
CY2023Q3 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2022Q3 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8754000 usd
CY2023Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
190420000 usd
CY2022Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
171176000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-617862000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1339569000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2359000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15078000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26256000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6145569000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
475182000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6647876000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
448926000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
502307000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
276613000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
323038000 usd
CY2023Q3 ph Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
-142224000 usd
CY2023Q2 ph Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
-175625000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
56000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10800000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.81
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4847488000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4232775000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
110055000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
123705000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
24334000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
23708000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
134389000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
147413000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
222759000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
244799000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
53854000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
78239000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
650827000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
650827000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
387854000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
387854000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128472550 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128425002 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1890891 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1517406 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130363441 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129942408 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.07
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.99
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.98
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
172255 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
887307 shares
CY2014Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
35000000 shares
CY2023Q3 us-gaap Goodwill
Goodwill
10523129000 usd
CY2023Q3 ph Debt Instrument Debt To Debt Shareholders Equity Ratio
DebtInstrumentDebtToDebtShareholdersEquityRatio
0.54
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
11000000 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
16000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10338279000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
651072000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-221714000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.48
CY2023Q3 us-gaap Dividends Cash
DividendsCash
190420000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
49747000 usd
CY2023Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2014000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10574950000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8859920000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
388037000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-301712000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.33
CY2023Q2 us-gaap Goodwill
Goodwill
10628594000 usd
CY2023Q3 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
10891000 usd
CY2023Q3 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
10520000 usd
CY2023Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-105836000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11156524000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2964566000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11285588000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2834974000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
156000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000000 usd
CY2023Q3 ph Finite Lived Intangible Asset Expected Amortization Current Fiscal Year
FiniteLivedIntangibleAssetExpectedAmortizationCurrentFiscalYear
565000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
543000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
539000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
533000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
524000000 usd
CY2023Q3 us-gaap Commercial Paper
CommercialPaper
1600000000 usd
CY2023Q2 us-gaap Commercial Paper
CommercialPaper
1800000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
111000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
111000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
24000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
2000000 usd
CY2023Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
40000000 usd
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
27143000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
21578000 usd
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
977358000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
787417000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
134468000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
117794000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22455000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-166278000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
820435000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
503345000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000076334-23-000064-index-headers.html Edgar Link pending
0000076334-23-000064-index.html Edgar Link pending
0000076334-23-000064.txt Edgar Link pending
0000076334-23-000064-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ph-20230930.htm Edgar Link pending
ph-20230930.xsd Edgar Link pending
ph9302023ex31a.htm Edgar Link pending
ph9302023ex31b.htm Edgar Link pending
ph9302023ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
ph-20230930_cal.xml Edgar Link unprocessable
ph-20230930_lab.xml Edgar Link unprocessable
ph-20230930_def.xml Edgar Link unprocessable
ph-20230930_pre.xml Edgar Link unprocessable
ph-20230930_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending